CTOR
CTOR
NASDAQ · Biotechnology

Citius Oncology Inc

$1.13
+0.02 (+1.80%)
As of Feb 8, 2:11 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 15.40M 13.64M 13.89M
Net Income -704,326 -740,627 -795,931
EPS
Profit Margin -4.6% -5.4% -5.7%
Rev Growth +4.1% +16.3% -0.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 15.41M 17.03M 15.62M
Total Equity 69.35M 57.68M 68.86M
D/E Ratio 0.22 0.30 0.23
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,183,474 -997,072 -1,062,628
Free Cash Flow -738,508 -859,127 -679,392